nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—alcohol dependence	0.457	1	CbGaD
Sulfadiazine—CYP2E1—Disulfiram—alcohol dependence	0.144	0.363	CbGbCtD
Sulfadiazine—CYP2E1—Citalopram—alcohol dependence	0.103	0.259	CbGbCtD
Sulfadiazine—CYP2C9—Disulfiram—alcohol dependence	0.0752	0.189	CbGbCtD
Sulfadiazine—CYP3A4—Disulfiram—alcohol dependence	0.0437	0.11	CbGbCtD
Sulfadiazine—CYP3A4—Citalopram—alcohol dependence	0.0312	0.0784	CbGbCtD
Sulfadiazine—Muscle contracture—Citalopram—alcohol dependence	0.00576	0.0635	CcSEcCtD
Sulfadiazine—Hepatic necrosis—Disulfiram—alcohol dependence	0.00519	0.0572	CcSEcCtD
Sulfadiazine—Eruption—Disulfiram—alcohol dependence	0.00491	0.0541	CcSEcCtD
Sulfadiazine—Goitre—Acamprosate—alcohol dependence	0.00416	0.0459	CcSEcCtD
Sulfadiazine—Neuritis—Disulfiram—alcohol dependence	0.00404	0.0445	CcSEcCtD
Sulfadiazine—Necrolysis epidermal—Citalopram—alcohol dependence	0.00393	0.0433	CcSEcCtD
Sulfadiazine—Diuresis—Citalopram—alcohol dependence	0.00287	0.0317	CcSEcCtD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00286	0.0517	CbGpPWpGaD
Sulfadiazine—Goitre—Citalopram—alcohol dependence	0.00249	0.0275	CcSEcCtD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00237	0.0428	CbGpPWpGaD
Sulfadiazine—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00207	0.0375	CbGpPWpGaD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00201	0.0364	CbGpPWpGaD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00171	0.031	CbGpPWpGaD
Sulfadiazine—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00165	0.0182	CcSEcCtD
Sulfadiazine—Hepatic necrosis—Citalopram—alcohol dependence	0.00153	0.0169	CcSEcCtD
Sulfadiazine—Hepatitis—Disulfiram—alcohol dependence	0.00152	0.0167	CcSEcCtD
Sulfadiazine—CYP2E1—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00151	0.0273	CbGpPWpGaD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.0015	0.0272	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00133	0.024	CbGpPWpGaD
Sulfadiazine—Burning sensation—Citalopram—alcohol dependence	0.00128	0.0141	CcSEcCtD
Sulfadiazine—Polyuria—Acamprosate—alcohol dependence	0.00123	0.0135	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00114	0.0126	CcSEcCtD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0011	0.0199	CbGpPWpGaD
Sulfadiazine—CYP2E1—Vitamin A and Carotenoid Metabolism—ADH1A—alcohol dependence	0.00107	0.0194	CbGpPWpGaD
Sulfadiazine—Purpura—Naltrexone—alcohol dependence	0.00106	0.0117	CcSEcCtD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00106	0.0191	CbGpPWpGaD
Sulfadiazine—Skin discolouration—Citalopram—alcohol dependence	0.000987	0.0109	CcSEcCtD
Sulfadiazine—CYP2C8—CYP2E1 reactions—CYP2E1—alcohol dependence	0.000986	0.0178	CbGpPWpGaD
Sulfadiazine—Oliguria—Citalopram—alcohol dependence	0.000967	0.0107	CcSEcCtD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.000934	0.0169	CbGpPWpGaD
Sulfadiazine—Pancreatitis—Acamprosate—alcohol dependence	0.000914	0.0101	CcSEcCtD
Sulfadiazine—CYP2E1—Vitamin A and Carotenoid Metabolism—ADH4—alcohol dependence	0.000912	0.0165	CbGpPWpGaD
Sulfadiazine—Aplastic anaemia—Citalopram—alcohol dependence	0.000837	0.00922	CcSEcCtD
Sulfadiazine—Depression—Acamprosate—alcohol dependence	0.000829	0.00914	CcSEcCtD
Sulfadiazine—Stomatitis—Acamprosate—alcohol dependence	0.00081	0.00893	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000804	0.0146	CbGpPWpGaD
Sulfadiazine—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.000802	0.0145	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.000794	0.0144	CbGpPWpGaD
Sulfadiazine—Depression—Naltrexone—alcohol dependence	0.000784	0.00864	CcSEcCtD
Sulfadiazine—Sepsis—Citalopram—alcohol dependence	0.000773	0.00852	CcSEcCtD
Sulfadiazine—Hepatitis—Acamprosate—alcohol dependence	0.000746	0.00823	CcSEcCtD
Sulfadiazine—Hallucination—Acamprosate—alcohol dependence	0.000743	0.00818	CcSEcCtD
Sulfadiazine—Polyuria—Citalopram—alcohol dependence	0.000737	0.00812	CcSEcCtD
Sulfadiazine—Vascular purpura—Citalopram—alcohol dependence	0.000723	0.00797	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Citalopram—alcohol dependence	0.000716	0.0079	CcSEcCtD
Sulfadiazine—Hepatitis—Naltrexone—alcohol dependence	0.000706	0.00778	CcSEcCtD
Sulfadiazine—Hallucination—Naltrexone—alcohol dependence	0.000703	0.00774	CcSEcCtD
Sulfadiazine—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000698	0.0126	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000696	0.0126	CbGpPWpGaD
Sulfadiazine—Tinnitus—Acamprosate—alcohol dependence	0.000696	0.00767	CcSEcCtD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000695	0.0126	CbGpPWpGaD
Sulfadiazine—Rash—Disulfiram—alcohol dependence	0.000679	0.00748	CcSEcCtD
Sulfadiazine—Headache—Disulfiram—alcohol dependence	0.000674	0.00743	CcSEcCtD
Sulfadiazine—Purpura—Citalopram—alcohol dependence	0.000671	0.0074	CcSEcCtD
Sulfadiazine—Chills—Acamprosate—alcohol dependence	0.00067	0.00738	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000666	0.0121	CbGpPWpGaD
Sulfadiazine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000663	0.012	CbGpPWpGaD
Sulfadiazine—Hypoglycaemia—Citalopram—alcohol dependence	0.000663	0.0073	CcSEcCtD
Sulfadiazine—Tinnitus—Naltrexone—alcohol dependence	0.000658	0.00726	CcSEcCtD
Sulfadiazine—Chills—Naltrexone—alcohol dependence	0.000634	0.00698	CcSEcCtD
Sulfadiazine—CYP2C8—Xenobiotics—CYP2E1—alcohol dependence	0.000611	0.0111	CbGpPWpGaD
Sulfadiazine—Ataxia—Citalopram—alcohol dependence	0.000608	0.0067	CcSEcCtD
Sulfadiazine—CYP2C8—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000588	0.0106	CbGpPWpGaD
Sulfadiazine—Vertigo—Acamprosate—alcohol dependence	0.000584	0.00643	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000582	0.00642	CcSEcCtD
Sulfadiazine—Leukopenia—Acamprosate—alcohol dependence	0.000582	0.00641	CcSEcCtD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000576	0.0104	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000567	0.0103	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000566	0.0102	CbGpPWpGaD
Sulfadiazine—Convulsion—Acamprosate—alcohol dependence	0.000563	0.0062	CcSEcCtD
Sulfadiazine—Arthralgia—Acamprosate—alcohol dependence	0.000553	0.0061	CcSEcCtD
Sulfadiazine—Pancreatitis—Citalopram—alcohol dependence	0.000548	0.00604	CcSEcCtD
Sulfadiazine—CYP2E1—Tryptophan metabolism—MAOB—alcohol dependence	0.000534	0.00967	CbGpPWpGaD
Sulfadiazine—Convulsion—Naltrexone—alcohol dependence	0.000533	0.00587	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Acamprosate—alcohol dependence	0.00053	0.00584	CcSEcCtD
Sulfadiazine—Arthralgia—Naltrexone—alcohol dependence	0.000523	0.00577	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000519	0.00572	CcSEcCtD
Sulfadiazine—Anorexia—Acamprosate—alcohol dependence	0.000506	0.00557	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000502	0.00553	CcSEcCtD
Sulfadiazine—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.000497	0.009	CbGpPWpGaD
Sulfadiazine—Depression—Citalopram—alcohol dependence	0.000497	0.00548	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000494	0.00545	CcSEcCtD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00049	0.00888	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00049	0.00887	CbGpPWpGaD
Sulfadiazine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000489	0.00538	CcSEcCtD
Sulfadiazine—Stomatitis—Citalopram—alcohol dependence	0.000486	0.00535	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000483	0.00532	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000482	0.00872	CbGpPWpGaD
Sulfadiazine—Insomnia—Acamprosate—alcohol dependence	0.00048	0.00529	CcSEcCtD
Sulfadiazine—Anorexia—Naltrexone—alcohol dependence	0.000478	0.00527	CcSEcCtD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000478	0.00866	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000469	0.00849	CbGpPWpGaD
Sulfadiazine—Agranulocytosis—Citalopram—alcohol dependence	0.000465	0.00513	CcSEcCtD
Sulfadiazine—Decreased appetite—Acamprosate—alcohol dependence	0.000461	0.00508	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000458	0.00505	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000457	0.00504	CcSEcCtD
Sulfadiazine—CYP2E1—Tryptophan metabolism—ALDH2—alcohol dependence	0.000454	0.00822	CbGpPWpGaD
Sulfadiazine—Insomnia—Naltrexone—alcohol dependence	0.000454	0.005	CcSEcCtD
Sulfadiazine—Hepatitis—Citalopram—alcohol dependence	0.000447	0.00493	CcSEcCtD
Sulfadiazine—Hallucination—Citalopram—alcohol dependence	0.000445	0.00491	CcSEcCtD
Sulfadiazine—Decreased appetite—Naltrexone—alcohol dependence	0.000436	0.00481	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000434	0.00478	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000433	0.00477	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—ADH6—alcohol dependence	0.000427	0.00774	CbGpPWpGaD
Sulfadiazine—Erythema multiforme—Citalopram—alcohol dependence	0.000423	0.00466	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000422	0.00765	CbGpPWpGaD
Sulfadiazine—Urticaria—Acamprosate—alcohol dependence	0.000421	0.00464	CcSEcCtD
Sulfadiazine—Abdominal pain—Acamprosate—alcohol dependence	0.000419	0.00462	CcSEcCtD
Sulfadiazine—Body temperature increased—Acamprosate—alcohol dependence	0.000419	0.00462	CcSEcCtD
Sulfadiazine—Tinnitus—Citalopram—alcohol dependence	0.000417	0.0046	CcSEcCtD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000416	0.00754	CbGpPWpGaD
Sulfadiazine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00041	0.00452	CcSEcCtD
Sulfadiazine—Chills—Citalopram—alcohol dependence	0.000402	0.00442	CcSEcCtD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000399	0.00722	CbGpPWpGaD
Sulfadiazine—Urticaria—Naltrexone—alcohol dependence	0.000399	0.00439	CcSEcCtD
Sulfadiazine—Abdominal pain—Naltrexone—alcohol dependence	0.000397	0.00437	CcSEcCtD
Sulfadiazine—Body temperature increased—Naltrexone—alcohol dependence	0.000397	0.00437	CcSEcCtD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000392	0.0071	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Acamprosate—alcohol dependence	0.000391	0.00431	CcSEcCtD
Sulfadiazine—Pruritus—Acamprosate—alcohol dependence	0.000375	0.00413	CcSEcCtD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000373	0.00676	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Naltrexone—alcohol dependence	0.00037	0.00407	CcSEcCtD
Sulfadiazine—CYP2C8—Biological oxidations—ADH6—alcohol dependence	0.000369	0.00669	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000365	0.00661	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Acamprosate—alcohol dependence	0.000363	0.004	CcSEcCtD
Sulfadiazine—Pruritus—Naltrexone—alcohol dependence	0.000355	0.00391	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—ADH1A—alcohol dependence	0.000354	0.00641	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00035	0.00634	CbGpPWpGaD
Sulfadiazine—Vertigo—Citalopram—alcohol dependence	0.00035	0.00386	CcSEcCtD
Sulfadiazine—Leukopenia—Citalopram—alcohol dependence	0.000349	0.00384	CcSEcCtD
Sulfadiazine—Diarrhoea—Naltrexone—alcohol dependence	0.000343	0.00378	CcSEcCtD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000339	0.00614	CbGpPWpGaD
Sulfadiazine—Convulsion—Citalopram—alcohol dependence	0.000338	0.00372	CcSEcCtD
Sulfadiazine—Vomiting—Acamprosate—alcohol dependence	0.000337	0.00372	CcSEcCtD
Sulfadiazine—Rash—Acamprosate—alcohol dependence	0.000334	0.00368	CcSEcCtD
Sulfadiazine—Dermatitis—Acamprosate—alcohol dependence	0.000334	0.00368	CcSEcCtD
Sulfadiazine—Headache—Acamprosate—alcohol dependence	0.000332	0.00366	CcSEcCtD
Sulfadiazine—Arthralgia—Citalopram—alcohol dependence	0.000332	0.00365	CcSEcCtD
Sulfadiazine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000328	0.00594	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000325	0.00589	CbGpPWpGaD
Sulfadiazine—Vomiting—Naltrexone—alcohol dependence	0.000319	0.00352	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Citalopram—alcohol dependence	0.000318	0.0035	CcSEcCtD
Sulfadiazine—Rash—Naltrexone—alcohol dependence	0.000316	0.00349	CcSEcCtD
Sulfadiazine—Dermatitis—Naltrexone—alcohol dependence	0.000316	0.00348	CcSEcCtD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000315	0.00571	CbGpPWpGaD
Sulfadiazine—Nausea—Acamprosate—alcohol dependence	0.000315	0.00347	CcSEcCtD
Sulfadiazine—Headache—Naltrexone—alcohol dependence	0.000314	0.00346	CcSEcCtD
Sulfadiazine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000314	0.00568	CbGpPWpGaD
Sulfadiazine—Thrombocytopenia—Citalopram—alcohol dependence	0.000311	0.00343	CcSEcCtD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000309	0.0056	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ADH1A—alcohol dependence	0.000306	0.00554	CbGpPWpGaD
Sulfadiazine—Anorexia—Citalopram—alcohol dependence	0.000303	0.00334	CcSEcCtD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000303	0.00548	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—ADH4—alcohol dependence	0.000301	0.00545	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000301	0.00544	CbGpPWpGaD
Sulfadiazine—Nausea—Naltrexone—alcohol dependence	0.000298	0.00328	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000298	0.00539	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000297	0.00538	CbGpPWpGaD
Sulfadiazine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00029	0.00319	CcSEcCtD
Sulfadiazine—Insomnia—Citalopram—alcohol dependence	0.000288	0.00317	CcSEcCtD
Sulfadiazine—Decreased appetite—Citalopram—alcohol dependence	0.000276	0.00305	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000274	0.00302	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00027	0.00488	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000263	0.00476	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ADH4—alcohol dependence	0.00026	0.00471	CbGpPWpGaD
Sulfadiazine—Gastrointestinal pain—Citalopram—alcohol dependence	0.00026	0.00286	CcSEcCtD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000257	0.00466	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—ADH7—alcohol dependence	0.000256	0.00463	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000254	0.00459	CbGpPWpGaD
Sulfadiazine—Urticaria—Citalopram—alcohol dependence	0.000253	0.00278	CcSEcCtD
Sulfadiazine—Body temperature increased—Citalopram—alcohol dependence	0.000251	0.00277	CcSEcCtD
Sulfadiazine—Abdominal pain—Citalopram—alcohol dependence	0.000251	0.00277	CcSEcCtD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00025	0.00453	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000249	0.00451	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000248	0.00449	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000246	0.00446	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GGT2—alcohol dependence	0.000245	0.00444	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Citalopram—alcohol dependence	0.000234	0.00258	CcSEcCtD
Sulfadiazine—Pruritus—Citalopram—alcohol dependence	0.000225	0.00248	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—ADH1B—alcohol dependence	0.000224	0.00406	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000224	0.00405	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ADH7—alcohol dependence	0.000221	0.00401	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000219	0.00397	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Citalopram—alcohol dependence	0.000218	0.0024	CcSEcCtD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000215	0.00388	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GGT2—alcohol dependence	0.000212	0.00384	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000212	0.00383	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000211	0.00381	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000209	0.00379	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000206	0.00374	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000206	0.00372	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000204	0.00369	CbGpPWpGaD
Sulfadiazine—Vomiting—Citalopram—alcohol dependence	0.000202	0.00223	CcSEcCtD
Sulfadiazine—Rash—Citalopram—alcohol dependence	0.0002	0.00221	CcSEcCtD
Sulfadiazine—Dermatitis—Citalopram—alcohol dependence	0.0002	0.00221	CcSEcCtD
Sulfadiazine—Headache—Citalopram—alcohol dependence	0.000199	0.00219	CcSEcCtD
Sulfadiazine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000198	0.00359	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000196	0.00355	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000196	0.00354	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ADH1B—alcohol dependence	0.000194	0.00351	CbGpPWpGaD
Sulfadiazine—Nausea—Citalopram—alcohol dependence	0.000189	0.00208	CcSEcCtD
Sulfadiazine—CYP2E1—Biological oxidations—MAOB—alcohol dependence	0.000186	0.00337	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.00018	0.00326	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000173	0.00313	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000169	0.00306	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000168	0.00305	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000167	0.00303	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000164	0.00297	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000162	0.00294	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000161	0.00291	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—ALDH2—alcohol dependence	0.000158	0.00286	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000158	0.00286	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000157	0.00285	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.00014	0.00253	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000138	0.0025	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000138	0.00249	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	0.000137	0.00247	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000136	0.00247	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000136	0.00246	CbGpPWpGaD
Sulfadiazine—Sulfanilamide—CYP2E1—alcohol dependence	0.000135	0.528	CrCbGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000134	0.00243	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000131	0.00237	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000127	0.00231	CbGpPWpGaD
Sulfadiazine—Dapsone—CYP2E1—alcohol dependence	0.000121	0.471	CrCbGaD
Sulfadiazine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000119	0.00215	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GGT1—alcohol dependence	0.000116	0.0021	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000114	0.00206	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000111	0.00201	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000111	0.002	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00011	0.002	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00011	0.00199	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	0.000109	0.00198	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000108	0.00195	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000104	0.00189	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—MAOA—alcohol dependence	0.000104	0.00188	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.0001	0.00182	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	9.08e-05	0.00164	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—MAOA—alcohol dependence	8.99e-05	0.00163	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	8.97e-05	0.00162	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	8.89e-05	0.00161	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	8.77e-05	0.00159	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	8.63e-05	0.00156	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GGT1—alcohol dependence	8.16e-05	0.00148	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	7.34e-05	0.00133	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—MAOA—alcohol dependence	7.32e-05	0.00132	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH6—alcohol dependence	7.31e-05	0.00132	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	7.29e-05	0.00132	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—POMC—alcohol dependence	6.77e-05	0.00123	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH6—alcohol dependence	6.32e-05	0.00114	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH1A—alcohol dependence	6.05e-05	0.0011	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.91e-05	0.00107	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	5.86e-05	0.00106	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—POMC—alcohol dependence	5.85e-05	0.00106	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	5.78e-05	0.00105	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	5.38e-05	0.000975	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH1A—alcohol dependence	5.23e-05	0.000947	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH4—alcohol dependence	5.15e-05	0.000932	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH6—alcohol dependence	5.14e-05	0.000931	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	4.83e-05	0.000874	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—POMC—alcohol dependence	4.76e-05	0.000862	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH4—alcohol dependence	4.45e-05	0.000806	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH7—alcohol dependence	4.38e-05	0.000792	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH1A—alcohol dependence	4.26e-05	0.000771	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GGT2—alcohol dependence	4.2e-05	0.00076	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.85e-05	0.000697	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADH1B—alcohol dependence	3.84e-05	0.000695	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH7—alcohol dependence	3.78e-05	0.000685	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GGT2—alcohol dependence	3.63e-05	0.000657	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH4—alcohol dependence	3.62e-05	0.000656	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH6—alcohol dependence	3.39e-05	0.000614	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADH1B—alcohol dependence	3.32e-05	0.000601	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MAOB—alcohol dependence	3.18e-05	0.000576	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—POMC—alcohol dependence	3.14e-05	0.000569	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.14e-05	0.000568	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH7—alcohol dependence	3.08e-05	0.000557	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GGT2—alcohol dependence	2.95e-05	0.000534	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.81e-05	0.000509	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MAOB—alcohol dependence	2.75e-05	0.000498	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDH2—alcohol dependence	2.7e-05	0.00049	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADH1B—alcohol dependence	2.7e-05	0.000489	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH4—alcohol dependence	2.39e-05	0.000432	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDH2—alcohol dependence	2.34e-05	0.000423	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GOT2—alcohol dependence	2.3e-05	0.000416	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.25e-05	0.000407	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MAOB—alcohol dependence	2.24e-05	0.000405	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH7—alcohol dependence	2.03e-05	0.000368	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GOT2—alcohol dependence	1.99e-05	0.00036	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GGT1—alcohol dependence	1.98e-05	0.000359	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GOT1—alcohol dependence	1.98e-05	0.000359	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GGT2—alcohol dependence	1.95e-05	0.000352	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDH2—alcohol dependence	1.9e-05	0.000344	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2E1—alcohol dependence	1.87e-05	0.000338	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.83e-05	0.000331	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.78e-05	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MAOA—alcohol dependence	1.78e-05	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GGT1—alcohol dependence	1.72e-05	0.000311	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GOT1—alcohol dependence	1.72e-05	0.000311	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GOT2—alcohol dependence	1.62e-05	0.000293	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MAOA—alcohol dependence	1.54e-05	0.000278	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1.52e-05	0.000275	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.49e-05	0.00027	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MAOB—alcohol dependence	1.48e-05	0.000267	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GGT1—alcohol dependence	1.4e-05	0.000253	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GOT1—alcohol dependence	1.4e-05	0.000253	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.25e-05	0.000227	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MAOA—alcohol dependence	1.25e-05	0.000227	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.21e-05	0.00022	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—POMC—alcohol dependence	1.16e-05	0.00021	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.07e-05	0.000193	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1e-05	0.000182	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—POMC—alcohol dependence	1e-05	0.000181	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GOT1—alcohol dependence	9.21e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GGT1—alcohol dependence	9.21e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MAOA—alcohol dependence	8.25e-06	0.000149	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—POMC—alcohol dependence	8.15e-06	0.000147	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—EP300—alcohol dependence	7.68e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—EP300—alcohol dependence	6.64e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—EP300—alcohol dependence	5.4e-06	9.78e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—POMC—alcohol dependence	5.37e-06	9.73e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—EP300—alcohol dependence	3.56e-06	6.45e-05	CbGpPWpGaD
